keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
FTISADTSK is an endogenous stable signature peptide derived from Trastuzumab, which can be accurately assessed using selected reaction monitoring (SRM).
説明 | FTISADTSK is an endogenous stable signature peptide derived from Trastuzumab, which can be accurately assessed using selected reaction monitoring (SRM). |
分子量 | 969.06 |
分子式 | C42H68N10O16 |
CAS No. | 1431957-73-1 |
keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
FTISADTSK 1431957-73-1 Inhibitor inhibitor inhibit